SK pharmteco Capacity Update October 2024: Small Molecule

In this presentation, we will delve into SK pharmteco’s comprehensive capabilities in supporting small molecule programs across all stages of development. With over 80 years of industry expertise and a global production capacity of approximately 1,000 m³, SK pharmteco is uniquely equipped to deliver scalable, reliable, and high-quality solutions tailored to the specific needs of your small molecule drug substance projects. From initial discovery to final commercial production, SK pharmteco’s innovative technologies and experienced teams are dedicated to ensuring the success of every phase of your program.

Join us to discover how SK pharmteco’s integrated approach — combining advanced manufacturing, cutting-edge technologies, and a commitment to excellence — can accelerate the development and delivery of your small molecule therapeutics. Whether you are in the early stages of drug discovery or preparing for commercial-scale production, SK pharmteco’s expertise and global network provide the flexibility and support necessary to navigate the complexities of small molecule drug development.